AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration H2N2 - Curation (Istex)

Index « AbsEn.i » - entrée « necessary »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
necessarily < necessary < necessitates  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 54.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000086 (1999) Hunein F. Maassab [États-Unis] ; Martin L. Bryant [États-Unis]The development of live attenuated cold‐adapted influenza virus vaccine for humans
000139 (1975) J. L. Schulman [États-Unis] ; P. Palese [États-Unis]Susceptibility of different strains of influenza a virus to the inhibitory effects of 2-deoxy-2,3-dehydro- N -trifluoroacetylneuraminic acid (FANA)
000223 (1994) Yan Wu [États-Unis] ; Yang Liu [États-Unis]Viral induction of co-stimulatory activity on antigen-presenting cells bypasses the need for CD4+ T-cell help in CD8+ T-cell responses
000233 (2001) B. Schweiger [États-Unis]Nationale und globale Influenzasurveillance als Basis der jährlichen Impfstoffempfehlung
000249 (1999) J. Yoshimoto [Japon] ; M. Kakui [Japon] ; H. Iwasaki [Japon] ; T. Fujiwara [Japon] ; H. Sugimoto [Japon] ; N. Hattori [Japon]Identification of a novel HA conformational change inhibitor of human influenza virus
000264 (1997) T. M Sweet [États-Unis] ; H. F Maassab [États-Unis] ; K. Coelingh [États-Unis] ; M. L Herlocher [États-Unis]Creation of amantadine resistant clones of influenza type A virus using a new transfection procedure
000265 (1995) M. Aymard [France] ; M. F. Odelin [France] ; J. Million-Jolly [France]Immunité antigrippale
000331 (1974) C. Sweet [Royaume-Uni] ; J. Stephen [Royaume-Uni] ; H. Smith [Royaume-Uni]Purification of influenza viruses using disulphide-linked immunosorbents derived from rabbit antibody
000393 (1985) G. M. Air [États-Unis] ; L. R. Ritchie [États-Unis] ; W. G. Laver [Australie] ; P. M. Colman [Australie]Gene and protein sequence of an influenza neuraminidase with hemagglutinin activity
000429 (1998) Michael W. Shaw [États-Unis] ; Irina V. Kiseleva [Russie] ; Andrei Y. Egorov [Russie] ; Mark L. Hemphill [États-Unis] ; Xiyan Xu [États-Unis]Generation of influenza transfectants using purified recombinant nucleocapsid protein
000462 (1998) J. Banks [Royaume-Uni] ; E. Speidel [Royaume-Uni] ; D. J. Alexander [Royaume-Uni]Characterisation of an avian influenza A virus isolated from a human – is an intermediate host necessary for the emergence of pandemic influenza viruses?
000466 (2012) R. Allwinn [Allemagne] ; M. Bickel [Allemagne] ; C. Lassmann [Allemagne] ; S. Wicker [Allemagne] ; I. Friedrichs [Allemagne]“Trivalent influenza vaccination of healthy adults 3 years after the onset of swine-origin H1N1 pandemic: restricted immunogenicity of the new A/H1N1v constituent?”
000498 (1980) P. Brès [Suisse]Surveillance epidemiologique des grippes humaines dans le monde: Le programme de l'OMS
000509 (2012) R. K. Saxena [Inde] ; P. Tripathi [Inde] ; G. Rawat [Inde]Pandemism of swine flu and its prospective drug therapy
000513 (1975) D. Sprengel [Allemagne]H2O2-fuel cells fed with a H2N2-mixture and air
000577 (2000) Susan Duhaut [Royaume-Uni] ; Nigel J. Dimmock [Royaume-Uni]Approximately 150 Nucleotides from the 5′ End of an Influenza A Segment 1 Defective Virion RNA Are Needed for Genome Stability during Passage of Defective Virus in Infected Cells
000607 (1998) C. Scholtissek [États-Unis] ; G. Quack [Allemagne] ; H. D Klenk [Allemagne] ; R. G Webster [États-Unis]How to overcome resistance of influenza A viruses against adamantane derivatives
000684 (1996) Christoph Scholtissek [Allemagne]Molecular evolution of influenza viruses
000A14 (1978) Brian R. Murphy [États-Unis] ; Frank T. Wood [États-Unis] ; Judith G. Massicot [États-Unis] ; Susan B. Spring [États-Unis] ; Robert M. Chanock [États-Unis]Temperature-sensitive mutants of influenza virus XV. The genetic and biological characterization of a recombinant influenza virus containing two is lesions produced by mating two complementing, single lesion is mutants
000A58 (2000) E. Starick ; A. R Mer-Oberd Rfer [Allemagne] ; O. Werner [Allemagne]Type‐ and Subtype‐Specific RT‐PCR Assays for Avian Influenza A Viruses (AIV)
000A75 (2002) J. Wood [Royaume-Uni] ; K. Nicholson [Royaume-Uni] ; I. Stephenson [Royaume-Uni] ; M. Zambon [Royaume-Uni] ; R. Newman [Royaume-Uni] ; D. Major [Royaume-Uni] ; A. Podda [Italie]Experience with the clinical development of influenza vaccines for potential pandemics

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "necessary" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "necessary" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    H2N2V1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    necessary
}}
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 14 19:59:40 2020. Site generation: Thu Mar 25 15:38:26 2021